Home › B-Cell Lymphoma › Minnesota › Rochester

Pag-aaral pangklinika para sa B-Cell Lymphoma sa Rochester, MN

Isang pag-aaral para sa B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Rochester. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Nagre-recruitPhase 3

Mayo Clinic Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Mayo Clinic - Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Nagre-recruitPhase 2

Research Site, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Nagre-recruitPhase 1/2

Mayo Clinic Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06634589

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1/2

Research Site, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07123454

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

Mayo Clinic Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Mayo Clinic, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Nagre-recruitPhase 1

Mayo Clinic in Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT03017820

CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

Nagre-recruitPhase 1

Mayo Clinic in Rochester, Rochester

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT04892277

Family Study of Lymphoproliferative Disorders

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Mayo Clinic, Rochester

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 14, 2025 · NCT00626496

Pag-aaral para sa B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Rochester

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.